IJMIX
Price
$16.31
Change
-$0.07 (-0.43%)
Updated
Sep 20 closing price
VMVAX
Price
$86.17
Change
-$0.37 (-0.43%)
Updated
Sep 20 closing price
Ad is loading...

IJMIX vs VMVAX

Header iconIJMIX vs VMVAX Comparison
Open Charts IJMIX vs VMVAXBanner chart's image
VY® JPMorgan Mid Cap Value I
Price$16.31
Change-$0.07 (-0.43%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$86.17
Change-$0.37 (-0.43%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
IJMIX vs VMVAX Comparison Chart
Loading...
VS
IJMIX vs. VMVAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IJMIX is a StrongBuy and VMVAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.5B vs. IJMIX (305M). VMVAX pays higher dividends than IJMIX: VMVAX (2.14) vs IJMIX (1.05). IJMIX was incepted earlier than VMVAX: IJMIX (22 years) vs VMVAX (13 years). VMVAX is a more actively managed with annual turnover of: 22.00 vs. IJMIX (10.00). IJMIX has a lower initial minimum investment than VMVAX: IJMIX (0) vs VMVAX (3000). VMVAX annual gain was more profitable for investors over the last year : 25.35 vs. IJMIX (20.89). VMVAX return over 5 years is better than : 48.82 vs. IJMIX (2.94).
IJMIXVMVAXIJMIX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years13 years-
Gain YTD8.62114.94658%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets305M30.5B1%
Annual Yield % from dividends1.052.1449%
Returns for 1 year20.8925.3582%
Returns for 3 years-8.1720.71-39%
Returns for 5 years2.9448.826%
Returns for 10 years-14.78100.88-15%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUUD0.790.01
+0.67%
Auddia
CTLT60.00-0.11
-0.18%
CATALENT
JAMF18.49-0.09
-0.48%
Jamf Holding Corp
ARCT20.61-0.41
-1.95%
Arcturus Therapeutics Holdings
ANVS8.47-0.17
-1.97%
Annovis Bio